Evaluation of Hypoglycemic and Hypolipidemic Activity of Buteamonosperma Fruit in Diabetic Human Subjects

Evaluation of the hypoglycemic activity of local Butea monosperma (Palas papra) fruit in normal and diabetic human volunteers was conducted. Sampling was accomplished in and around the city of Faisalabad, especially at the Khadija Mahmood Trust Hospital and at the University of Agriculture, Faisalabad, Pakistan. Volunteers were categorized into normal and diabetic subjects on the basis of their blood glucose levels. Male and female diabetic volunteers aged between 30 and 60 years participated in the study. All the diabetic volunteers suffered from diabetes type II, i.e. non-insulin-dependent diabetes mellitus (NIDDM). The subjects were divided into 5 groups as follows: Group A - Untreated normal subjects; Group B - Normal subjects who received powdered B. monosperma (3 g) in 30 mL of water for 30 days, orally; Group C - Control diabetic subjects; Group D - Diabetic subjects who received powdered (3 g) in 30 mL of water for 30 days, orally; and Group E - Diabetic subjects who received a 5-mg tablet b. I. d. of Daonil® (a standard oral antidiabetic drug) in 30 mL of water for 30 days. The oral administration of B. monosperma fruit to diabetic and normal subjects for 30 days decreased (P < 0.05) blood glucose, urine sugar, and plasma glycoprotein levels, as well as the lipid profile and the activity of liver enzymes. In conclusion, the powder of the medicinal plant B. monosperma fruit can be considered an effective and alternative treatment for diabetes.

Anahtar Kelimeler:

Key words: Butea monosperma fruit, glucose level, diabetic human volunteers

Evaluation of Hypoglycemic and Hypolipidemic Activity of Buteamonosperma Fruit in Diabetic Human Subjects

Keywords:

Key words: Butea monosperma fruit, glucose level, diabetic human volunteers,

PDF

___

1. Mentreddy RS. Medicinal plant species with potential antidiabetic properties. J Sci of Food and Agric 87: 743-750, 2007.
2. Sammad AS. Diabetes mellitus: A major health problem in Pakistan. Pak Med J 124: 1518, 1993.
3. Scheen JA. Drug treatment of non-insulin dependent diabetes mellitus in the 1990s: Achievement and future development. Drug 54: 355-368, 1997.
4. Wild S, Roglic A, Green R et al. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053, 2004.
5. Lyra R, Oliveira M, Lins D et al. Prevention of type 2 diabetes mellitus. Arq Bras Endocrinol Metabo 50: 239-249, 2006.
6. Shami SA, Jalili S, Bhatti S. Prevalence of non-insulin independent diabetes mellitus in Pakistan population. Pak Med J 30: 311-313, 1998.
7. Yeh GY, Eisenberg DM, Kaptchuk TJ et al. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 26: 1277-94, 2003.
8. Gorodeski GI. Update on cardiovascular disease in postmenopausal women. Best Pract Res Clin Obstet Gynaecol 16: 329-55, 2002.
9. American Diabetic Association. Position statement: Nutrition recommendations and Principles for people with diabetes mellitus. Diabetes Care. 17: 519-522, 1994.
10. Krause MV, Mahan LK. Food Nutrition and Diet Therapy. WB Saunders Company London, PP: 479-484, 1984.
11. Wu AM. Carbohydrate structural units in glycoproteins and polysaccharides as important legends for Gal and GalNAc reactive lectins. J Biomed Sci 10: 676-688, 2003.
12. Rahman MA, Zafar G, Shera AS. Changes in glycosylated proteins in long-term complications of diabetes mellitus. Biomed Pharmacother 44: 229-234, 1990.
13. Konukoglu D, Serin O, Akcay T et al. Relationship between diabetic angiopathic complications and serum total and lipid associated sialic acid concentrations. Med Sci Res 27: 53-55, 1999.
14. Han C, Hui O, Wang Y. Hypoglycaemic activity of saponin fraction extracted from Momordica charantia in PEG/salt aqueous two-phase systems. Nat Prod Res 22: 1112-9, 2008.
15. Han C, Li J, Hui O. Determination of trace elements in Jinqi, a traditional Chinese medicine. Biol Trace Elem Res 122: 122-6, 2008.
16. Han C, Cui B, Ou J. Comparison of vanadium-rich activity of three species fungi of basidiomycetes. Biol Trace Elem Res 127: 278-83, 2009.
17. Rai MK. A review on some antidiabetic plants of India. Ancient Science of Life 14: 42-54, 1995.
18. Venkatesh S, Reddy GO, Reddy BM et al. Antihyperglycemic activity of Caralluma attenuata. Fitoterapia 74: 274-279, 2003.
19. Jeyachandram R, Mahesh A. Enumeration of antidiabetic herbal flora of Tamil Nadu. Res J Med Plant 1: 1-5, 2007.
20. Mamta M, Shukla YN, Kumar S. Chemical constituents of Butea monosperma flowers. J Med & Aromatic Plant Sci 24: 120-125, 2002.
21. Niebes P. Determination of enzymes and degradation products of glycosaminoglycans metabolism in the serum of healthy and varicose subjects. Clin Chim Acta 42: 399-408, 1972.
22. Warren L. Thiobarbituric acid assay of sialic acid. J Biol Chem 234: 1971-1975, 1959.
23. Dische Z, Shettle LB. A specific color reaction of methyl pentoses and a spectrophotometric micro method for their determination. J Biol Chem 175: 596-603, 1948.
24. Neeley WE, O’Classen K, Gruber M. Determination of serum aspartate aminotransferase with pyridoxal 5’-phosphate in the Technicon SMAC and Du Pont aca compared and correlated with the IFCC recommended method. Clin Chem 31: 139-142, 1985.
25. Mercer DW. Simultaneous separation of serum creatine kinase and lactate dehydrogenase isoenzymes by ion–exchange column chromatography. Clin Chem 1102-1106, 1975.
26. Walls R, Kumar KS, Hochstein P. Aging of human erythrocytes. Arch Biochem Biophys 100: 119-128, 1976.
27. Werner M, Gabrielson DG, Eastman G. In: Clin Chem 21: 268, 1981.
28. Allain CC, Poon LS, Chon CSG et al. Enzymatic determination of total serum cholesterol. Clin Chem 20: 470-475, 1974.
29. Lopes-Virella MF. In: Clin Chem 23: 882, 1977.
30. AOAC. Official method of analysis. The Association of Analytical Chemists, Arlington, Virginia, USA, 1990.
31. Vijayvargia R, Monika K, Gupta S. Hypoglycemic effect of aqueous extract of Enicostetmma littorale, Blume (chhota chirayata) on alloxan induced diabetes mellitus in rats. Ind J Exp Biol 38: 781-784, 2000.
32. Satyanarayana T, Sarita T, Balaji M et al. Antihyperglycemic and hypoglycemic effect of Thespesia Populnea fruit in normal and alloxan-induced diabetes in rabbits. Saudi Pharm J 12: 107-111, 2005.
33. Iriadam M, Musa D, Gumushan H et al. Effect of two Turkish medicinal plants Artemisia herba-alba and Teucrium polium on blood glucose levels and other biochemical parameters in rabbits. J Cell and Molecular Biol 5: 19-24, 2006.
34. Pari L, Saravanan G. Antidiabetic effect of Cogent db, a herbal drug in alloxan induced diabetes mellitus. Comp Biochem Physiol Toxicol 131: 19-25, 2002.
35. Saravanan G, Pari L. Effect of Cogent db, an herbal drug on serum and tissue lipids metabolism in experimental hyperglycemic rats. Diabetes Obes Metab 5: 156-162, 2003.
36. Somogyi A, Ruzieska E, Blazovies A et al. Insulin treatment decreases the antioxidant defense mechanism in experimental diabetes. Med Sci Monit 11: BR206-BR211, 2005.
37. Massing MW, Sueta CA, Chowdhury M et al. Lipid management among coronary artery disease patients in diabetes mellitus or advanced age. American Journal of Cardiology 87: 646-664, 2001.
38. Ravi K, Rajasekaran S, Subramanian S. Antihyperlipidemic effect of Eugenia jambolana seed kernel on streptozotocininduced diabetes in rats. Food Chem Toxicol 43: 1433-1439, 2005.
39. Metz SA. Oxygenation products of archidonic acid: Third messengers of insulin release. Prostaglandins 27: 147-151, 1984.
40. Kakkar R, Mantha SV, Radhi J et al. Increased oxidative stress in rat liver and pancreas during progression of streptozotocininduced diabetes. Clin Sci 94: 623-632, 1998.
41. Patti ME, Virkamai A, Landaker EJ et al. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early post receptor insulin signaling events in skeletal muscles. Diabetes 48: 1562-1571, 1999.
42. Johnson A, Wales JK. Blood glycoprotein levels in diabetes mellitus. Diabetologia 12: 245-250, 1976.
43. Wiese TJ, Dunlap JA, Yorek MA. Effect of L-fucose and Dglucose concentration on L-fucoprotein metabolism in human Hep G2 cells and changes in fucosyltransferase and alfa-Lfucosidase activity in liver of diabetic rats. Biochim Biophys Acta 1335: 61-72, 1997.
44. Mobley PW, Metzger RP, Guilmetle JG et al. The effect of fasting, alloxan diabetes and streptozotocin diabetes on rat liver Darabinose (L-fucose) dehydrogenase activity. Biochem Med 6: 178-183, 1972.
45. Saladini M, Menabue L, Ferrani E. Binding ability of sialic acid towards biological and toxic metal ions. NMR, potentiometric and spectroscopic study. J Inorg Biochem 88: 61-68, 2002.
46. Sonmez H, Suer S, Gungor Z et al. Sialidase activities and sialic acid levels of the liver and serum from streptozotocin induced diabetic rats. Diabetes Res 32: 101-106, 1997.
47. Ozsoy-Sacan O, Karabulut-Bulan O, Bolkent S et al. Effects of Chard (Beta vulgaris L. varcicla) on the liver of the diabetic rats: a morphological and biochemical study. Biosci Biotechnol Biochem 68: 1640-1648, 2004.
48. Chaudry AR, Alam M, Ahmad M et al. Studies on medicinal herbs. II: effects of Colchicum luteum on biochemical parameters of rabbit serum. Fitoterapia. 64: 510-515, 1993.
49. Baraona EP, Pikkarainen M, Salaspuro F et al. Acute effects of ethanol on hepatic protein synthesis and secretion in the rat. Gastroenterol 79: 104, 1980.